Brian Angus

12PUBLICATIONS
80CO-AUTHORS
Innate immunityMedical virologyNanotoxicology, health and safetyGreenhouse gas inventories and fluxesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 27, 2026
Phase II multicentre double-blind randomised controlled trial of a Bivalent VaccInation against Salmonella Typhi and Paratyphi A (BiVISTA) using a controlled human infection model of paratyphoid A infection: study protocol.

Margarete Paganotti Vicentine, Naina McCann, Oisin Hennigan

|May 10, 2025
T cell memory response to MPXV infection exhibits greater effector function and migratory potential compared to MVA-BN vaccination.

Ji-Li Chen, Beibei Wang, Yongxu Lu

|May 24, 2023
Accelerating clinical development of a live attenuated vaccine against Salmonella Paratyphi A (VASP): study protocol for an observer-participant-blind randomised control trial of a novel oral vaccine using a human challenge model of Salmonella Paratyphi A infection in healthy adult volunteers.

Naina McCann, Katherine Emary, Nisha Singh

|Dec 18, 2020
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.

Katie J Ewer, Jordan R Barrett, Sandra Belij-Rammerstorfer

|Dec 18, 2020
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.

Jordan R Barrett, Sandra Belij-Rammerstorfer, Christina Dold

|Oct 20, 2020
Homologous and heterologous re-challenge with Salmonella Typhi and Salmonella Paratyphi A in a randomised controlled human infection model.

Malick M Gibani, Celina Jin, Sonu Shrestha

Pageof 2

Frequent Collaborators

9 joint publications

Andrew J Pollard

5 joint publications

Maheshi Nirmala Ramasamy

5 joint publications

Yama Mujadidi

5 joint publications

Katie J Ewer